| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |